Evidence map›Paper›PMID 35795278›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Elucidating the Neuroprotective Effect of

Amit Gupta, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Shivam Yadav, Khalid Anwer, Celia Vargas-De-La Cruz, Sridevi Chigurupati, Abdullah Farasani and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Plants (Basel, Switzerland) · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Amit GuptaChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Tapan BehlChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.ORCID https://orcid.org/0000-0003-0993-7708
Aayush SehgalChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Sukhbir SinghChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Neelam SharmaChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Shivam YadavYashraj Institute of Pharmacy, Lucknow, Uttar Pradesh, India.
Khalid AnwerDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.
Celia Vargas-De-La CruzDepartment of Pharmacology, Bromatology and Toxicology, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Sridevi ChigurupatiDepartment of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraidah 52571, Saudi Arabia.
Abdullah FarasaniBiomedical Research Unit, Medical Research Center, Jazan University, Jazan, Saudi Arabia.
Saurabh BhatiaNatural & Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, Nizwa, Oman.
Chitkara University · INJazan University · SANational University of San Marcos · PEPrince Sattam Bin Abdulaziz University · SAQassim University · SAUniversity of Nizwa · OM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes is considered one of the most encyclopedic metabolic disorders owing to an alarming rise in the number of patients, which is increasing at an exponential rate. With the current therapeutics, which only aims to provide symptomatic and momentary relief, the scientists are shifting gears to explore alternative therapies which not only can target diabetes but can also help in limiting the progression of diabetic complications including diabetic neuropathy (DN). Methods: Results: Parameters associated with the pathogenesis of diabetic neuropathy were evaluated. For general parameters, different doses of Conclusion: The leaves of

Identifiers

PMID35795278
PMCPMC9251095
OpenAlexW4283580268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.